| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/08/2005 | US20050198706 Lipases and methods of use |
| 09/08/2005 | US20050198705 Herbicide-resistant rice plant; biological pest control |
| 09/08/2005 | US20050198704 Chloroplast transgenesis of monocots: bioconfined genetically engineered monocot crops that will eliminate transgene flow |
| 09/08/2005 | US20050198703 Sweet potato sporamin gene promoter |
| 09/08/2005 | US20050198702 Expression vector comprising tissue specific regulatory sequences for generating transgenic plants with enhanced phytohormone, carbohydrate and fatty acid metabolism and/or biosynthesis |
| 09/08/2005 | US20050198701 Using recombinant zebrafish to propagating ornamental progeny in hatcheries; animal husbandry |
| 09/08/2005 | US20050198699 Knockin non-human animal and tissue-specific MnSOD knockout non-human animal |
| 09/08/2005 | US20050198698 Transgenic cattle for use as bioreactor for heterologus gene expression |
| 09/08/2005 | US20050198697 Transgenic mollusk and method for producing the same |
| 09/08/2005 | US20050198696 Animal model for lymphocyte development; treating blood, cell proliferative and kidney disorders |
| 09/08/2005 | US20050198694 Truncated fragments of alpha-synuclein in Lewy body disease |
| 09/08/2005 | US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs |
| 09/08/2005 | US20050197491 Comprises brain glycoprotein for use in identifying modulators which can be used in diagnosis and treatment of nervous system disorders |
| 09/08/2005 | US20050197315 siRNA expression system and method for producing functional gene knock-down cell using the system |
| 09/08/2005 | US20050197313 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
| 09/08/2005 | US20050197312 Transcription factor RNA interference reagents and methods of use thereof |
| 09/08/2005 | US20050197311 Vector comprising first polynucleotide encoding glucose responsive mRNA instability element, second polynucleotide encoding reporter polypeptide and promoter sequence; fluorescence based high throughput screening |
| 09/08/2005 | US20050197310 TGaseII polypeptide antibodies; pulmonary, kidney, liver or ocular fibrosis; cardiac hypertrophy, atherosclerosis, restenosis; Alzheimer's and Parkinson's disease |
| 09/08/2005 | US20050197309 Antisense modulation of dual specific phosphatase 5 expression |
| 09/08/2005 | US20050197305 Methods and compositions for blocking progression of a disease state |
| 09/08/2005 | US20050197304 Stimulating regeneration with naked DNA encoding bioactive agents; does not cause insertional mutagenesis, host immunogenicity or tissues targeting difficulties |
| 09/08/2005 | US20050197295 Modified annexin proteins and methods for preventing thrombosis |
| 09/08/2005 | US20050197293 Use of an IL-1 antagonist for treating arthritis |
| 09/08/2005 | US20050197284 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease |
| 09/08/2005 | US20050196866 Transforming the host cell with one or more genes that encode at least one enzyme that uses NADPH as a cofactor; pyridine nucleotide transhydrogenase that catalyzes NADPH formation; cell produces at least 50% more NADPH after transformation |
| 09/08/2005 | US20050196865 Using chinese hamster ovaries as bioreactors for propagation of heterologous gene sequences |
| 09/08/2005 | US20050196864 Propagating transgenic nervous system tissue for use as tools in treatment of parkinson's disease |
| 09/08/2005 | US20050196863 Such as 1-(2,3-dihydroxypropyl)-2,4,6-trimethylpyridinium hexafluorophosphate; transfecting eukaryotic cells |
| 09/08/2005 | US20050196862 DNA cassette for cellular expression of small RNA |
| 09/08/2005 | US20050196860 Novel EPS8 compounds for therapy and diagnosis and methods for using same |
| 09/08/2005 | US20050196858 Isolation, selection and propagation of animal transgenic stem cells |
| 09/08/2005 | US20050196854 Using domiphen bromide to selectively precipitate viral particles from DNA mixtures; ion echange chromatography |
| 09/08/2005 | US20050196848 Process for the fermentative production of L-amino acids by attenuation of the poxB gene |
| 09/08/2005 | US20050196847 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum |
| 09/08/2005 | US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing |
| 09/08/2005 | US20050196837 DNA construct comprising centromeric, telomeric and genomic regions for use in transfer of heterologous sequences into cells |
| 09/08/2005 | US20050196836 Gamma-glutamylcysteine producing yeast |
| 09/08/2005 | US20050196833 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 09/08/2005 | US20050196830 Amino acid modified polypeptides |
| 09/08/2005 | US20050196829 identifying polymorphisms in gene sequences coding Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A); identifying modulator for prevention and treatment of allergic disorders |
| 09/08/2005 | US20050196808 Products and processes for modulating peptide-peptide binding domain interactions |
| 09/08/2005 | US20050196807 Gene mining system and method |
| 09/08/2005 | US20050196806 Prostate specific antigen oligoepitope peptide |
| 09/08/2005 | US20050196802 peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily; use drug screening |
| 09/08/2005 | US20050196801 Screening assays for agonists or antagonists or receptor activator of NF-kappaB |
| 09/08/2005 | US20050196799 Use of representations of DNA for genetic analysis |
| 09/08/2005 | US20050196798 Nucleoside triphosphate diphosphohydrolase (NTPDASE 8) and uses thereof |
| 09/08/2005 | US20050196797 PI-3-kinase-related kinase polypeptide for use as tool in identifying modulators for prevntion and treatment of cell proliferation disorders |
| 09/08/2005 | US20050196793 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers |
| 09/08/2005 | US20050196788 isolated bacterial oxidase, comprising an oxidase that regenerates NADP+, NAD+, or both; isolated from Lactobacillus |
| 09/08/2005 | US20050196783 Nucleotide sequences coding r-ounidabout (robo) regulatory protein (SLIT polypeptides) for use in treatment and prevention of nervous system disorders; nerve cell function modulators |
| 09/08/2005 | US20050196782 Universal amplification of fragmented RNA |
| 09/08/2005 | US20050196778 Nucleic acid analysis apparatus |
| 09/08/2005 | US20050196777 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 09/08/2005 | US20050196774 Modified nucleotide sequences with enhanced geneic expression in heterologous host cells |
| 09/08/2005 | US20050196772 Nucleotide sequences coding lysosomal membrane glycoprotein for use as tool in prevention and treatment of bone disorders |
| 09/08/2005 | US20050196769 Preparing DNA from paraffin-embedded, formalin-fixed tissue samples for promoter methylation analysis by deparaffinizing the samples; boiling them in citrate buffer; and extracting DNA from them; hypermethylation of ATM gene promoter correlates with decreased overall head & neck cancer survival |
| 09/08/2005 | US20050196767 siNA molecule comprising a double-stranded structure that down-regulates expression of GAB2 (Growth factor receptor-bound protein 2 (GRB2) , where the siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 09/08/2005 | US20050196766 Producing variant lipid acyltransferase for enhancing fatty acid transfer between phosphatidylcholine and cholesterol |
| 09/08/2005 | US20050196759 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 09/08/2005 | US20050196756 Simultaneously detecting mutually diffferent nucleotide sequences in a sample via multiplex polymerase chain reaction |
| 09/08/2005 | US20050196754 Nucleotide sequences coding modified immunoglobulin for use in immunodiagnostics and therapy |
| 09/08/2005 | US20050196752 Genomic sequence of the 5-Lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 09/08/2005 | US20050196751 Receptor protein is capable of activating transcription of desired gene when in presence of agonist and when bound to antagonist; gene therapy; gene expression inhibition; transgenic cells, animals |
| 09/08/2005 | US20050196521 Ink jet application of 3-hydroxyacyl coenzyme A containing solution and enzyme catalyzed polymerization; biological testing probes and arrays |
| 09/08/2005 | US20050196435 Encapsulating drug; drug delivery |
| 09/08/2005 | US20050196427 Engineered proteins, and methods of making and using |
| 09/08/2005 | US20050196407 Isolated polypeptide comprising a claimed amino acid sequence |
| 09/08/2005 | US20050196406 Which display a passenger polypeptide on the outer surface of a biological entity; displayed passenger polypeptide is capable of interacting or binding with a given ligand |
| 09/08/2005 | US20050196405 Pneumococcal surface protein c (pspc), epitopic regions and strain selection thereof, and uses therefor |
| 09/08/2005 | US20050196400 Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 09/08/2005 | US20050196399 antibody capable of specifically recognizing two regions of the A4 peptide/A beta 4, wherein the first region comprises the amino acid sequence AEFRHDSGY and the second region comprises the amino acid sequence YEVHHQKLVFFAEDVG |
| 09/08/2005 | US20050196398 Nucleotide sequences coding specialized hydrolase for use as tool in identifying modulator for prevention and treatment of nervous system disorders; enzyme inhibitors |
| 09/08/2005 | US20050196397 Factor IX/factor IXa activating antibodies and antibody derivatives |
| 09/08/2005 | US20050196390 Detecting metalloproteinase inhibitor in sample of tissue, serum, urine, tumor; detectable label is a monoclonal antibody; radioimmunoassay, enzyme linked immunoassay |
| 09/08/2005 | US20050196388 Lactic acid bacterial culture for obtaining fermented dairy products from milk supplemented with glucose; fermenting yogurt |
| 09/08/2005 | US20050196384 Deliver a heterologous nucleic acid sequence in prime-boost vaccination regimens; sequence encodes the same gene product or antigen in the recombinant adenovirus vector of the first and second serotype; viral antigens are Ebola, measles, West Nile, HIV, SIV; cross neutralization not an issue |
| 09/08/2005 | US20050196381 Lentivirus vector-based approaches for generating an immune response to HIV in humans |
| 09/08/2005 | DE10393473T5 Trap-Tagging: ein neuartiges Verfahren zur Identifikation und Reinigung von RNA-Protein-Komplexen Trap tagging: a novel method for the identification and purification of RNA-protein complexes |
| 09/08/2005 | DE102004008445A1 New recombinant microorganisms comprising increased concentration of D-amino acid oxidase, L-amino acid dehydrogenase, co-substrate NADH enzyme and catalase than the parental microorganism, useful to prepare L-amino acids from D-amino acids |
| 09/07/2005 | EP1571448A1 Fluorescent indicator using fret |
| 09/07/2005 | EP1571223A2 L-cysteine-producing microorganism and a method for producing L-cysteine |
| 09/07/2005 | EP1571222A2 Fluorescent genetic fragments and the correspondant transgenic fish |
| 09/07/2005 | EP1571221A2 Genes involved in tolerance to environmental stress |
| 09/07/2005 | EP1571220A2 Universal chloroplast integration and expression vectors, transformed plants and products thereof |
| 09/07/2005 | EP1571219A2 Plant regulatory sequences for selective control of gene expression |
| 09/07/2005 | EP1571218A1 Animal immunocontraceptives expressed in plants and uses thereof |
| 09/07/2005 | EP1571217A1 Increasing production of proteins in gram-positive microorganisms |
| 09/07/2005 | EP1571216A2 Phosphodiesterase 8A |
| 09/07/2005 | EP1571214A2 Immunogenic detoxified mutant toxin |
| 09/07/2005 | EP1571213A1 Bifidobacterium longum AR81 (KCCM-10492) enabling inhibition of rotavirus and active protein separated therefrom |
| 09/07/2005 | EP1571212A1 Recombinat protein containing albumin multimer |
| 09/07/2005 | EP1571211A1 Antibodies against lesion tissue |
| 09/07/2005 | EP1571209A1 Method of detecting target base sequence of rna interference, method of designing polynucleotide base sequence causing rna interference, method of constructing double-stranded polynucleotide, method of regulating gene expression, base sequence processing apparatus, program for running base sequence |
| 09/07/2005 | EP1571207A1 Novel cellulase tolerant to surfactants |
| 09/07/2005 | EP1571199A2 Multiply-substituted protease variants |
| 09/07/2005 | EP1571160A1 Kit for assaying human low-molecular weight cd14 and antibody |
| 09/07/2005 | EP1571157A1 LIPIN1 function |
| 09/07/2005 | EP1570854A1 Drug containing angiotensin convertase |
| 09/07/2005 | EP1570733A1 Mammal for studying DCIS and the effect of inactivated tumor suppressors |